For CSF NfH the effects were smaller than for CSF NfL for FTLD (n = 59) compared to controls (n = 108, 0.74; 95% CI 0.40–1.08) and not significant for FTLD compared to AD (Petzold et al., 2007). The gene discussed is NEFL; the disease is Alzheimer disease.